KLK3 and posterior cortical atrophy: We tested this hypothesis in the present study, focusing on a very special subset of IR PCa patients with PSA <10 ng/mL, ISUP grade group 3, and clinical stage up to cT2b, a frequently situation in clinical practice, which needs active treatments when life expectancy is at least 10 years.